Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer
The researchers show that disrupting lipid formulation reverses treatment resistance and the immunosuppressive microenvironment.
Read More
Motion sickness brain circuit may provide new options for treating obesity
A better understanding of how the brain regulates body temperature during motion sickness may provide unconventional targets for the treatment of obesity.
Read More
Preventing onset and development of heart failure with preserved ejection fraction
The findings point at a promising new therapeutic target for mitigating heart lipid toxicity and heart failure.
Read More
Paving the way to better diagnosis and treatment for Langerhans cell histiocytosis
The findings create possibilities for risk-stratification regimens that can be better tailored to individual patients.
Read More
Baylor College of Medicine wins 2025 STAT Madness!
This is the second year in a row that Baylor has won the popular vote in STAT’s bracket-style research competition.
Read More
New CDKL genes linked to neurodevelopmental disorders
Working with fruit flies, the team uncovered a mechanism by which the defective variants may cause the neurological symptoms in affected individuals.
Read More
New study helps researchers engineer better gene therapies
This study will make basic research on AAV vectors for gene delivery and preclinical gene therapy studies in mice more efficient and reproducible.
Read More
Gasdermin D emerges as a potential therapeutic target for atrial fibrillation
This study reveals that gasdermin D plays a novel role in the development of atrial fibrillation through multifaceted mechanisms.
Read More
Postpartum female preference for cooler temperatures linked to brain changes
Changes in temperature preference in postpartum female mice were associated with significant alterations in the preoptic area of the brain.
Read More
Restoring heart function in Myotonic Dystrophy Type 1
The findings are relevant to current therapeutic approaches for DM1 that are based on increasing MBNL protein.
Read More